AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3536400 — intervention group
Group type: EXPERIMENTAL
Intervention: sucralfate
Number of subjects: 134
Study 2656368 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 micrograms arbaprostil
Number of subjects: 64
Study 2656368 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms arbaprostil
Number of subjects: 64
Study 2656368 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 31133906 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital health tools for early psychosis
Number of subjects: 48
Study 29354917 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation training combined with modified shu‐acupuncture for 8 weeks, acupuncture at specified points once a day for 6 days with 1 day rest.
Number of subjects: 71
Study 29354917 — intervention group
Group type: COMPARATOR
Intervention: Simple rehabilitation training for 8 weeks, including quadriceps femoris exercises, range of knee joint motion, and limb walking on the affected side.
Number of subjects: 71
Study 26165981 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Imagery (GI) intervention
Number of subjects: 36
Study 23275644 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted distal gastrectomy
Number of subjects: 920
Study 23275644 — intervention group
Group type: COMPARATOR
Intervention: Open distal gastrectomy
Number of subjects: 920
Study 21185506 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular (LV) dysfunction at diagnosis
Number of subjects: 198
Study 21185506 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral regurgitation (MR) at diagnosis
Number of subjects: 198
Study 21185506 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic root dilation at diagnosis
Number of subjects: 198
Study 21185506 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory inflammatory markers (erythrocyte sedimentation rate and serum albumin)
Number of subjects: 198
Study 21185506 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic root size
Number of subjects: 198
Study 18338263 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 2 mg and glycopyrrolate 0.4 mg intramuscularly
Number of subjects: 7
Study 18338263 — intervention group
Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 7
Study 16931684 — intervention group
Group type: EXPERIMENTAL
Intervention: Preincisional paravertebral block (PVB)
Number of subjects: 60
Study 16931684 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PVB)
Number of subjects: 60
Study 12607809 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported patient pain measured using the Visual Analog Scale and the Medical Outcomes Study Short Form‐36 (MOS SF‐36) pain scale.
Number of subjects: 509
Study 11180026 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg
Number of subjects: 18
Study 11180026 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 800 mg
Number of subjects: 18
Study 11180026 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 8938010 — intervention group
Group type: EXPERIMENTAL
Intervention: Haptic bias instructions
Number of subjects: 0
Study 8938010 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual bias instructions
Number of subjects: 0
Study 1403999 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple therapy (five sessions)
Number of subjects: 56
Study 1403999 — intervention group
Group type: COMPARATOR
Intervention: Control group (no couple therapy)
Number of subjects: 56
Study 2988737 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy twice a week (40.00 Gy/5 weeks) with misonidazole 1.2 g/m2 given orally 3 1/2 to 4 hours before treatment
Number of subjects: 244
Study 2988737 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy twice a week (40.00 Gy/5 weeks) with placebo
Number of subjects: 244
Study 2988737 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy five times a week (50.00 Gy/5 weeks) with misonidazole 0.48 g/m2 given orally 3 1/2 to 4 hours before treatment
Number of subjects: 244
Study 2988737 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy five times a week (50.00 Gy/5 weeks) with placebo
Number of subjects: 244
Study 2988737 — intervention group
Group type: EXPERIMENTAL
Intervention: CCNU chemotherapy (120 mg/m2 every 6 weeks)
Number of subjects: 244
Study 2988737 — intervention group
Group type: COMPARATOR
Intervention: No chemotherapy
Number of subjects: 244
Study 29404913 — intervention group
Group type: EXPERIMENTAL
Intervention: Technique feature analysis
Number of subjects: 90
Study 29404913 — intervention group
Group type: EXPERIMENTAL
Intervention: Involvement load hypothesis
Number of subjects: 90
Study 29404913 — intervention group
Group type: COMPARATOR
Intervention: Sentence making, composition, and reading comprehension tasks
Number of subjects: 90
Study 27600013 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia and patient-controlled intravenous analgesia (PCIA)
Number of subjects: 100
Study 27600013 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia combined with epidural anesthesia and PCIA
Number of subjects: 100
Study 27600013 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia combined with epidural anesthesia and patient-controlled epidural analgesia (PCEA)
Number of subjects: 100
Study 25037674 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR in patients with BAV
Number of subjects: 28
Study 25037674 — intervention group
Group type: COMPARATOR
Intervention: TAVR in patients with tricuspid aortic valves (control group)
Number of subjects: 28
Study 22396403 — intervention group
Group type: EXPERIMENTAL
Intervention: Perturbation of the arm at random times during decision formation
Number of subjects: 0
Study 22396403 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous flow of an evolving decision variable to the motor system
Number of subjects: 0
Study 20675951 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally targeted educational program on colorectal health (90 minutes)
Number of subjects: 539
Study 20675951 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 539
Study 19255992 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual midazolam (0.3 mg/kg)
Number of subjects: 264
Study 19255992 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral chloral hydrate (50 mg/kg)
Number of subjects: 264
Study 16186281 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin lispro
Number of subjects: 21
Study 16186281 — intervention group
Group type: COMPARATOR
Intervention: Human regular insulin
Number of subjects: 21
Study 11505405 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, doxorubicin, and vincristine (CAV)
Number of subjects: 119
Study 11505405 — intervention group
Group type: COMPARATOR
Intervention: Single-agent carboplatin
Number of subjects: 119
Study 11505405 — intervention group
Group type: EXPERIMENTAL
Intervention: CAV
Number of subjects: 119
Study 11505405 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin
Number of subjects: 119
Study 9877257 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents as the agents of change (experimental intervention)
Number of subjects: 60
Study 9877257 — intervention group
Group type: COMPARATOR
Intervention: Children as the agents of change (conventional intervention)
Number of subjects: 60
Study 8078438 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic parenteral nutrition
Number of subjects: 0
Study 8078438 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic total parenteral nutrition
Number of subjects: 0
Study 8078438 — intervention group
Group type: COMPARATOR
Intervention: Continuous nutrient infusion
Number of subjects: 0
Study 2510312 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin
Number of subjects: 111
Study 2510312 — intervention group
Group type: COMPARATOR
Intervention: Tetracycline
Number of subjects: 111
Study 1097619 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) early (0.40 FIO2; PaO2 < 60 mm Hg)
Number of subjects: 0
Study 1097619 — intervention group
Group type: COMPARATOR
Intervention: Continuous Positive Airway Pressure (CPAP) late (0.70 FIO2; PaO2 < 60 mm Hg)
Number of subjects: 0
Study 30629770 — intervention group
Group type: EXPERIMENTAL
Intervention: HP
Number of subjects: 388
Study 30629770 — intervention group
Group type: COMPARATOR
Intervention: G + T
Number of subjects: 388
Study 27501360 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed-based exercise program (stationary recumbent cycling, 2 sessions per week, 30 minutes each, including interval training with ten 20-second fast cadence intervals)
Number of subjects: 26
Study 27501360 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed-based exercise program
Number of subjects: 26
Study 27501360 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 26
Study 26586255 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained using the Gadjah Mada nurse-client communication guideline (4 hours of training with role-plays, supportive information, and feedback sessions)
Number of subjects: 0
Study 26586255 — intervention group
Group type: COMPARATOR
Intervention: Control group (untrained students)
Number of subjects: 0
Study 24392462 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (72 patients)
Number of subjects: 127
Study 24392462 — intervention group
Group type: COMPARATOR
Intervention: Microsurgical discectomy (55 patients)
Number of subjects: 127
Study 24392462 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Conservative and Operative)
Number of subjects: 127
Study 22344061 — intervention group
Group type: EXPERIMENTAL
Intervention: Weightlifting
Number of subjects: 30
Study 22344061 — intervention group
Group type: COMPARATOR
Intervention: Kettlebell training
Number of subjects: 30
Study 19887581 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher serum total cholesterol concentration (high versus low quintile, >276.7 versus <203.9 mg/dL)
Number of subjects: 29093
Study 19887581 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater HDL cholesterol (high versus low quintile, >55.3 versus <36.2 mg/dL)
Number of subjects: 29093
Study 17699531 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking programme (30 minutes brisk walking three days a week, n = 44)
Number of subjects: 106
Study 17699531 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking programme (30 minutes brisk walking five days a week, n = 42)
Number of subjects: 106
Study 17699531 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 106
Study 14987626 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep muscle stimulation
Number of subjects: 15
Study 14987626 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous needle insertion
Number of subjects: 15
Study 11669568 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk assessment, pressure ulcer grading, pressure-reducing mattress, and educational programme
Number of subjects: 146
Study 11669568 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing and treatment routines
Number of subjects: 146
Study 9853541 — intervention group
Group type: COMPARATOR
Intervention: Wheat bran supplement (high-fiber control)
Number of subjects: 24
Study 9853541 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistant starches (RS2 and RS3)
Number of subjects: 24
Study 7865392 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic legging
Number of subjects: 0
Study 7865392 — intervention group
Group type: EXPERIMENTAL
Intervention: Inelastic legging
Number of subjects: 0
Study 7865392 — intervention group
Group type: COMPARATOR
Intervention: No legging (Control)
Number of subjects: 0
Study 7865392 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic legging and Inelastic legging
Number of subjects: 0
Study 2678390 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemosorption
Number of subjects: 9
Study 2678390 — intervention group
Group type: COMPARATOR
Intervention: Placebo-hemosorption
Number of subjects: 9
Study 1095283 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenmetozole (100 mg and 200 mg)
Number of subjects: 40
Study 1095283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 30604197 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannuronic acid (500 mg, two capsules per day orally for 12 weeks)
Number of subjects: 288
Study 30604197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 288
Study 30604197 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 288
Study 30604197 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannuronic acid
Number of subjects: 288
Study 29231473 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy group (acupuncture + modified weitong xiaopi formula)
Number of subjects: 90
Study 29231473 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine group (modified weitong xiaopi formula)
Number of subjects: 90
Study 29231473 — intervention group
Group type: COMPARATOR
Intervention: Western medication group (mosapride citrate capsules)
Number of subjects: 90
Study 25822117 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intentions using standard instructions
Number of subjects: 79
Study 25822117 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intentions with a supporting tool
Number of subjects: 79
Study 25822117 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 79
Study 23739503 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg of L-carnitine per day
Number of subjects: 60
Study 23739503 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 mg of L-carnitine per day
Number of subjects: 60
Study 23739503 — intervention group
Group type: COMPARATOR
Intervention: Basic therapy only (control group)
Number of subjects: 60
Study 21384388 — intervention group
Group type: EXPERIMENTAL
Intervention: 2,940 nm Er:YAG laser device at adjustable depths (250 µm, 500 µm, 1,000 µm) and four coagulation levels
Number of subjects: 3
Study 21384388 — intervention group
Group type: EXPERIMENTAL
Intervention: 2,940 nm Er:YAG laser device
Number of subjects: 3
Study 19398668 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 476
Study 19398668 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 476
Study 17416110 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (n=20): bolus dose of 0.5 mg x kg(‐1) followed by continuous infusion of 2 microg x kg(‐1) x min(‐1) before surgery.
Number of subjects: 40
Study 17416110 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=20): normal saline in the same manner as ketamine group.
Number of subjects: 40
Study 17416110 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (n=20)
Number of subjects: 40
Study 17416110 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=20)
Number of subjects: 40
Study 15361700 — intervention group
Group type: COMPARATOR
Intervention: Serum oxLDL/beta2GPI complexes in patients with chronic renal failure (CRF)
Number of subjects: 0
Study 15361700 — intervention group
Group type: COMPARATOR
Intervention: Serum oxLDL/beta2GPI complexes in patients with chronic nephritis (CN)
Number of subjects: 0
Study 15361700 — intervention group
Group type: COMPARATOR
Intervention: Malondialdehyde-modified LDL in all patient groups
Number of subjects: 0
Study 11195257 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide 600 mg
Number of subjects: 52
Study 11195257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 9301431 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous L-arginine 8 g
Number of subjects: 20
Study 9301431 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous L-arginine 30 g
Number of subjects: 20
Study 2167573 — intervention group
Group type: EXPERIMENTAL
Intervention: Miansan (mianserin)
Number of subjects: 42
Study 2167573 — intervention group
Group type: COMPARATOR
Intervention: Pyrazidol
Number of subjects: 42
Study 7019033 — intervention group
Group type: EXPERIMENTAL
Intervention: lysozyme chloride at doses of 60 to 170 mg/day for 4 to 24 weeks
Number of subjects: 260
Study 7019033 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 260
Study 30794114 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive feedback
Number of subjects: 35
Study 30794114 — intervention group
Group type: COMPARATOR
Intervention: Negative feedback
Number of subjects: 35
Study 30794114 — intervention group
Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 35
Study 29020601 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (45mg)
Number of subjects: 27
Study 29020601 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0mg)
Number of subjects: 27
Study 26438225 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-tailored intervention (personalised videos)
Number of subjects: 510
Study 26438225 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-tailored intervention (personalised text advice)
Number of subjects: 510
Study 26438225 — intervention group
Group type: COMPARATOR
Intervention: Control group (generic physical activity articles)
Number of subjects: 510
Study 26438225 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-tailored intervention
Number of subjects: 510
Study 26438225 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-tailored intervention
Number of subjects: 510
Study 26438225 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 510
Study 23584570 — intervention group
Group type: EXPERIMENTAL
Intervention: FOYC intervention (delivered in 2004/2005)
Number of subjects: 0
Study 23584570 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no training)
Number of subjects: 0
Study 22648100 — intervention group
Group type: COMPARATOR
Intervention: High-fidelity simulator (LapSim)
Number of subjects: 228
Study 22648100 — intervention group
Group type: COMPARATOR
Intervention: Low-fidelity simulator (FLS)
Number of subjects: 228
Study 20455246 — intervention group
Group type: EXPERIMENTAL
Intervention: Pexacerfont 100 mg/day
Number of subjects: 260
Study 20455246 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram 20 mg/day
Number of subjects: 260
Study 20455246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study 18606032 — intervention group
Group type: EXPERIMENTAL
Intervention: Video‐Feedback Intervention to Promote Positive Parenting and Sensitive Discipline (VIPP‐SD)
Number of subjects: 130
Study 18606032 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 130
Study 15739655 — intervention group
Group type: EXPERIMENTAL
Intervention: Information leaflet along with verbal information
Number of subjects: 20
Study 15739655 — intervention group
Group type: COMPARATOR
Intervention: Verbal information alone
Number of subjects: 20
Study 11918753 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (enalapril 10 mg/day and eprosartan 300 mg/day)
Number of subjects: 20
Study 11918753 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (20 mg/day)
Number of subjects: 20
Study 11918753 — intervention group
Group type: COMPARATOR
Intervention: Eprosartan (600 mg/day)
Number of subjects: 20
Study 11918753 — intervention group
Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 20
Study 10512404 — intervention group
Group type: COMPARATOR
Intervention: Suction biopsy
Number of subjects: 29
Study 10512404 — intervention group
Group type: EXPERIMENTAL
Intervention: Grasp biopsy
Number of subjects: 29
Study 8973851 — intervention group
Group type: EXPERIMENTAL
Intervention: epirubicin 75 mg/m2
Number of subjects: 40
Study 8973851 — intervention group
Group type: COMPARATOR
Intervention: mitozantrone 14 mg/m2
Number of subjects: 40
Study 1333098 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogens at 0.625 mg per day
Number of subjects: 29
Study 1333098 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogens at 1.25 mg per day
Number of subjects: 29
Study 1333098 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 3909910 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 days of postoperative catheterisation
Number of subjects: 0
Study 3909910 — intervention group
Group type: COMPARATOR
Intervention: 28 days of postoperative catheterisation
Number of subjects: 0
Study 31305214 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin therapy for 3 months
Number of subjects: 537
Study 31305214 — intervention group
Group type: EXPERIMENTAL
Intervention: CVAI
Number of subjects: 537
Study 31305214 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperinsulinemic-euglycemic clamp
Number of subjects: 537
Study 28581645 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional protein-rich drink
Number of subjects: 12
Study 28581645 — intervention group
Group type: COMPARATOR
Intervention: Standard breakfast
Number of subjects: 12
Study 28581645 — intervention group
Group type: COMPARATOR
Intervention: Fasted conditions
Number of subjects: 12
Study 27690762 — intervention group
Group type: EXPERIMENTAL
Intervention: AS03-adjuvanted trivalent inactivated influenza vaccine (AS03-TIV)
Number of subjects: 5187
Study 27690762 — intervention group
Group type: COMPARATOR
Intervention: Non-adjuvanted trivalent inactivated influenza vaccine (TIV)
Number of subjects: 5187
Study 27690762 — intervention group
Group type: EXPERIMENTAL
Intervention: AS03-TIV
Number of subjects: 5187
Study 27690762 — intervention group
Group type: COMPARATOR
Intervention: TIV
Number of subjects: 5187
Study 27690762 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical model based on A/H3N2 attack rates and HI antibody titers
Number of subjects: 5187
Study 25100080 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 10 mg once daily
Number of subjects: 452
Study 25100080 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 5 mg once daily
Number of subjects: 452
Study 25100080 — intervention group
Group type: COMPARATOR
Intervention: Teprenone 50 mg three times per day (active control)
Number of subjects: 452
Study 22340282 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA-PDT (20% solution of ALA applied for 1 hour, two sessions)
Number of subjects: 61
Study 22340282 — intervention group
Group type: COMPARATOR
Intervention: Imiquimod 5% cream (half a sachet applied twice weekly)
Number of subjects: 61
Study 22340282 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA-PDT
Number of subjects: 61